The global genomics market size was estimated at USD 21.76 billion in 2025 and is projected to reach USD 72.50 billion by 2033, growing at a CAGR of 18.2% from 2026 to 2033. The market is experiencing rapid expansion due to increasing adoption of genomics technologies across healthcare, biotechnology, pharmaceuticals, and life science research applications. The growth is strongly...

The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

As we enter 2026, the global clinical landscape is being redefined by deep-learning architectures that identify pathogenic variants with 99% accuracy. In North America and the European Union, the adoption of Artificial Intelligence In Genomics Market protocols has become a mandatory component of pediatric rare disease diagnostics. This shift is particularly evident in medical hubs...

Spain has emerged as a global leader in the 2026 fight against rare diseases, with the "Genómica España" initiative reaching its goal of diagnosing all pediatric rare conditions within six months. By leveraging a decentralized network of specialized "Rare Disease Hubs," the country has eliminated the diagnostic odyssey for thousands of families. The Spain Personalized...